PATENT CLAIM ANALYSIS

Application Number: 15903615
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "220000"]

Abstract:
Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, a NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.

Claim (Index 14):
The pharmaceutical composition of  claim 13 , wherein the excipient is selected from the group consisting of gelatin, sodium saccharin, stevioside, peppermint oil, any natural or artificial fruit, vegetable, flower, beverage or candy flavor, and combinations thereof.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 88.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15903529', '15066731', '14254136', '10428341', '14415322']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7703460662596091
- 35 USC 102 Novelty (BERT): 0.521435581020673
- Combined Prediction Score: 0.7454550177357155
- Mean Citation Score: 193.753596
- Max Citation Score: 319.43558
- Similarity Product: 234.51715102155444

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test